Home/Filings/4/0000950170-24-076867
4//SEC Filing

Dadoo Rajeev 4

Accession 0000950170-24-076867

CIK 0001671858other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 5:06 PM ET

Size

5.4 KB

Accession

0000950170-24-076867

Insider Transaction Report

Form 4
Period: 2024-06-20
Dadoo Rajeev
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-20+40,00040,000 total
    Exercise: $7.73Exp: 2034-06-19Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest in full on the earlier of June 20, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.

Documents

1 file

Issuer

ARS Pharmaceuticals, Inc.

CIK 0001671858

Entity typeother

Related Parties

1
  • filerCIK 0001951685

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 5:06 PM ET
Size
5.4 KB